New drug safety check for advanced bladder cancer in india

NCT ID NCT06862219

Recruiting now Disease control Sponsor: Astellas Pharma Global Development, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking the safety of enfortumab vedotin in 100 Indian adults whose bladder cancer has spread or come back after other treatments. Participants receive the drug through an IV every 4 weeks. The main goal is to track side effects, but researchers will also see if the drug shrinks tumors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: enfortumab vedotin
What this could lead to: If successful, this study could confirm that enfortumab vedotin is safe for Indian patients with advanced bladder cancer, supporting its use as a standard treatment option.
What could go wrong: This is a single-arm, open-label safety study with no comparison group, so it cannot prove effectiveness. Side effects like nerve damage, skin reactions, or fatigue may occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

transitional cell carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC UROTHELIAL CARCINOMA

Contacts and locations

Locations

Site IN91001
RECRUITING

Surat, India
Site IN91004
RECRUITING

Mumbai, Maharashtra, India
Site IN91005
RECRUITING

Varanasi, Uttar Pradesh, India
Site IN91006
RECRUITING

Kolkata, West Bengal, India
Site IN91007
RECRUITING

Vellore, Tamil Nadu, India
Site IN91008
RECRUITING

Mumbai, India
Site IN91009
RECRUITING

Nagpur, India
Site IN91010
RECRUITING

Bhubaneswar, India
Site IN91012
RECRUITING

Ahmedabad, India
Site IN91013
RECRUITING

Patna, Bihar, India
Site IN91015
RECRUITING

Kochi, Kerala, India
Site IN91016
RECRUITING

New Delhi, National Capital Territory of Delhi, India
Site IN91017
RECRUITING

Dumas, Surat, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.